nitrendipine has been researched along with Anterior Horn Cell Disease in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fratantoni, SA | 1 |
| Weisz, G | 1 |
| Pardal, AM | 1 |
| Reisin, RC | 1 |
| Uchitel, OD | 1 |
1 other study available for nitrendipine and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker.
Topics: Adult; Aged; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Evoked Potentials; Female; | 2000 |